Table 3. Effects of Previous Cannabinoid Exposure on Drug Self-Administration and Place Conditioning in Rodents.
Study | Subjects | Exposure drug | Exposure regimena | Age during exposure | Drug-free periodb | Test drugc | Age at start of testing | FR1 self-admin. | PR self-admin. | Place conditioningd |
---|---|---|---|---|---|---|---|---|---|---|
Norwood et al (2003) | Lewis rats | CP | 0.1→0.2 mg/kg/day for 16 days | Starting at PND 55–56 | 8 Days | Morphine | 11 Weeks | Male ↑ | ||
González et al (2003) | Wistar rats | THC | Dams given 5 mg/kg/day PO | Perinatal: GD5 through PND 24 | ⩾7 Weeks | Morphine …Food | ⩾10 Weeks | Female = e Male= … Female = Male = | ||
Gonzalez et al (2004) | Wistar rats | THC | 5 mg/kg/day for 7 days | Starting at 8–10 weeks | 0 Days | Morphine | Male = | |||
Solinas et al (2004) | S-D rats | THC | 2→8 mg/kg twice daily for 3 days | Starting at 10-12 weeks | 8 Days | Heroin | 12–13 Weeks | Male ↑ | Male = | |
Ellgren et al (2007) | L-E rats | THC | 1.5 mg/kg/day, intermittent (8 out of 22 days) | PND 28–49 | 1 week | Heroin | 8 Weeks | Male ↑ | ||
Biscaia et al (2008) | Wistar rats | CP | 0.4 mg/kg/day for 11 days | PND 35–45 | Morphine | 10 Weeks | Female = f Male ↑ | Female = Male= | ||
Tomasiewicz et al (2012) | L-E rats | THC | 1.5 mg/kg/day, intermittent (8 out of 22 days) | PND 28–49 | 5 Weeks | Heroin | 12 Weeks | Male ↑ Male with Penk KD = | ||
Stopponi et al (2014) | Wistar rats | THC | 2.5→10 mg/kg twice daily for 11 days | PND 35–45 | 30 Days | Heroin … Yohimbine reinstatement of heroin seeking | 11 Weeks | Male = … Male ↑ | ||
Vela et al (1998) | Wistar rats | THC | Dams given 5 mg/kg/day PO | Perinatal: GD5 through PND 1 | >11 Weeks | Morphine … Food | >11 Weeks | Female ↑ Male = ... Female = Male = | ||
Spano et al (2007) | L-E rats | THC | Dams given 0.15 mg/kg/day IV | Perinatal: GD5 through PND 2 | 8 Weeks | Heroin | 9 Weeks | Male =/↑g | ||
Morel et al (2009) | L-E rats | THCh | 5→10 mg/kg/day, intermittent (10 out of 14 days) | PND 35–48 | 7–14 Days | Morphinei | 9 Weeks | Maternally deprived male ↓j Nondeprived male = | Maternally deprived male ↓ Nondeprived male ↑ | |
Singh et al (2006) | Wistar rats | THC | 5 mg/kg/day for 10 days | PND 4–14 | 1 Week | Heroin | 3 Weeks | Male ↑ | ||
Cadoni et al (2013) | Lewis rats … Fischer rats | THC | 2→8 mg/kg twice daily for 3 days | PND 38–42 | 30 Days | Heroin | 10 Weeks | Lewis male = … Fischer male ↑ | ||
Rubio et al (1995) | Wistar rats | THC | Dams given 5 mg/kg/day PO | Perinatal: GD5 through PND 24 | >7 Weeks | Morphine | >10 Weeks | Female = k Male ↑ | ||
Rubio et al (1998) | Wistar rats | THC | Dams given 1, 5 or 20 mg/kg/day PO | Perinatal: GD5 through PND 24 | >7 weeks | Morphine | >10 Weeks | Female ↑l Male ↑ | ||
DiNieri et al (2011) | L-E rats | THC | Dams given 0.15 mg/kg/day IV | Perinatal: GD5 through PND 2 | 8 Weeks | Morphine | 9 Weeks | Male ↑ | ||
Jardinaud et al (2006) | CD1 mice | THC | 10 mg/kg/day for 10 days | 15 Days | Morphine | Male ↓ | ||||
Scherma et al (2016a, 2016b) | Lister-Hooded rats | THC | 2.5→10 mg/kg twice daily for 11 days | PND 45–55 | 15 Days | WIN 55212-2 | 10 Weeks | Male ↑ | ||
Valjent and Maldonado (2000) | CD1 mice | THC | 1 Or 5 mg/kg (single injection) | 1 Day | THC | Male ↑m | ||||
Wakeford et al (2016) | S-D rats | THC | 3.2 mg/kg/day, intermittent (8 out of 22 days) | PND 28–50 | 40 Days | THC | 13 Weeks | Male = n | ||
Hempel et al (2016) | S-D rats | THC | 3.2 mg/kg/day, intermittent (6 out of 12 days) | PND 71–82 | 3 Days | THC | 12 Weeks | Male = o | ||
Hyatt and Fantegrossi (2014) | NIH Swiss mice | THC | 1→100 mg/kg/day, intermittent (5 out of 10 days) | Starting at 8 weeks | 2 Days | JWH-018 (CB agonist) … MDMA | 10 Weeks | Male ↑p … Male = | ||
Rodriguez-Arias et al (2016) | OF1 mice | WIN | 0.1 or 0.5 mg/kg/day for 5 days | PND 27–31 | 3 Days | MDMA | 5 Weeks | Male ↑ | ||
Cortright et al (2011) | S-D rats | THC | 3 mg/kg/day intermittent (5 out of 13 days) | Adult | 10 Days | Amphetamine … Apomorphine | Male = … Male = | Male = … Male ↑ | ||
Panlilio et al (2007) | S-D rats | THC | 2→8 mg/kg twice daily for 3 days | Starting at 10–14 weeks | 8 Days | Cocaine | 12–14 Weeks | Male = | Male ↓ | |
Higuera-Matas et al (2008) | Wistar rats | CP | 0.4 mg/kg/day for 11 days | PND 28–38 | 7 Weeks | Cocaine … Food | 13 Weeks | Female ↑q Male = … Female = Male = | ||
Rodriguez-Arias et al (2016) | OF1 mice | WIN | 0.1 or 0.5 mg/kg/day for 5 days | PND 26–30 | 3 Days | WIN … Cocaine | PND 34 | Male = … Male ↑r | ||
Panlilio et al (2013) | S-D rats | THC | 2→8 mg/kg twice daily for 3 days | Starting at 10–12 weeks | 8 Days | Nicotine | 12–13 Weeks | Male ↑ | Male =/↑s | |
Economidou et al (2007) | Wistar rats | THCt | Dams given 5 mg/kg/day PO | Perinatal: GD 15–PND 9 | 8 Weeks | Ethanolu | 9 Weeks | Male = |
Abbreviations: PND, postnatal day; GD, gestational day; FR1, fixed-ratio one; PR, progressive ratio; SA, self-administration; PO, per os; CB, cannabinoid; L-E, Long-Evans; S-D, Sprague-Dawley; Penk KD, knockdown of proenkephalin in nucleus accumbens shell; CP, CP-55,940; WIN, WIN 55212-2; MDMA, (±)-3,4-methylenedioxymethamphetamine.
Symbols: →, dose escalated over days; …, different experiment in same study; ↑, enhanced relative to vehicle-treated controls; ↓, diminished relative to vehicle-treated controls; =, no change relative to vehicle-treated controls.
Treatments were intraperitoneal and given every day unless otherwise indicated.
Time between last exposure and start of behavioral testing.
Test drugs were intraperitoneal for place conditioning and intravenous for self-administration, unless otherwise noted.
Results involve conditioned place preference unless otherwise indicated.
Females had high morphine and food intake regardless of exposure treatment.
Females had high morphine intake regardless of exposure treatment.
THC exposure did not affect acquisition of responding, but decreased latency to the first response of the session, increased responding for a low dose of heroin, increased heroin intake when rats were acutely food deprived, and increased responding during extinction.
Dronabinol.
Oral self-administration of freely available morphine solution.
THC exposure prevented escalation of intake seen in vehicle-treated maternal deprivation group.
Nonsignificant trend for enhancement.
Smaller effect than in males.
THC-exposure potentiated conditioning of place preference when the training dose of THC was low and prevented conditioning of place aversion when the training dose of THC was high.
Combined taste- and place-conditioning procedure. Place preference did not occur in exposed or nonexposed rats.
Combined taste- and place-conditioning procedure. Place preference did not occur in exposed or nonexposed rats.
THC-exposure potentiated conditioning of place preference when the training dose of JWH-018 was low and prevented conditioning of place aversion when the training dose of JWH-018 was high.
Self-administration enhanced during first 7 days (acquisition phase), but not during last 14 days (maintenance phase).
WIN exposure enhance cocaine induced place preference in groups classified as high or low novelty-seeking, but place preference was only reinstated (after extinction training) by a priming injection of cocaine in the high novelty-seeking group.
THC exposure did not affect responding in a within-session PR test, but enhanced responding when the FR was increased across sessions.
THC was combined with either 3% ethanol or 4.2% sucrose (as a control condition) in the only source of drinking water.
Oral self-administration with lever press required for access.